Medidata Solutions, Inc. (MDSO) Analysts See $0.22 EPS

June 14, 2018 - By Jimmy Baldridge

Medidata Solutions, Inc. (NASDAQ:MDSO) LogoInvestors sentiment decreased to 0.95 in 2018 Q1. Its down 0.76, from 1.71 in 2017Q4. It dived, as 36 investors sold Medidata Solutions, Inc. shares while 74 reduced holdings. 28 funds opened positions while 76 raised stakes. 62.26 million shares or 1.96% more from 61.06 million shares in 2017Q4 were reported.
Tci Wealth Advsr invested 0% in Medidata Solutions, Inc. (NASDAQ:MDSO). Kames Capital Public Limited Liability Corp reported 27,377 shares. Utd Svcs Automobile Association has invested 0% in Medidata Solutions, Inc. (NASDAQ:MDSO). Cap Fincl Advisers Limited Company stated it has 0.02% in Medidata Solutions, Inc. (NASDAQ:MDSO). Essex Invest Management Ltd Liability Corporation holds 0.08% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO) for 9,499 shares. Citigroup reported 0% stake. Cap Fund Mngmt Sa has 0.06% invested in Medidata Solutions, Inc. (NASDAQ:MDSO) for 153,897 shares. Private Cap Advisors holds 0.15% or 7,400 shares. Prudential Public Limited stated it has 75,000 shares. Arrowmark Colorado Hldgs Ltd Liability holds 1.04 million shares. Aperio Gp Lc owns 12,017 shares or 0% of their US portfolio. Bessemer Group Inc reported 0% of its portfolio in Medidata Solutions, Inc. (NASDAQ:MDSO). Secor Capital Limited Partnership has 94,651 shares for 0.49% of their portfolio. 7,200 are held by Cubist Systematic Strategies Lc. Clearbridge Invests accumulated 0.13% or 2.18M shares.

Since December 19, 2017, it had 0 insider buys, and 12 insider sales for $6.10 million activity. On Monday, June 4 TAYLOR ROBERT sold $285,681 worth of Medidata Solutions, Inc. (NASDAQ:MDSO) or 3,630 shares. 26,836 shares were sold by de Vries Glen Michael, worth $1.88M. Another trade for 10,395 shares valued at $728,170 was sold by Otner Michael I.. Sherif Tarek also sold $1.89 million worth of Medidata Solutions, Inc. (NASDAQ:MDSO) on Monday, March 12.

Analysts expect Medidata Solutions, Inc. (NASDAQ:MDSO) to report $0.22 EPS on July, 17.They anticipate $0.04 EPS change or 22.22 % from last quarter’s $0.18 EPS. MDSO’s profit would be $13.02M giving it 92.05 P/E if the $0.22 EPS is correct. After having $0.24 EPS previously, Medidata Solutions, Inc.’s analysts see -8.33 % EPS growth. The stock increased 1.25% or $1 during the last trading session, reaching $81. About 401,377 shares traded. Medidata Solutions, Inc. (NASDAQ:MDSO) has risen 4.39% since June 14, 2017 and is uptrending. It has underperformed by 8.18% the S&P500.

Medidata Solutions, Inc. (NASDAQ:MDSO) Ratings Coverage

Among 9 analysts covering Medidata Solutions (NASDAQ:MDSO), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Medidata Solutions had 13 analyst reports since January 3, 2018 according to SRatingsIntel. Piper Jaffray maintained it with “Buy” rating and $83.0 target in Thursday, February 8 report. The company was maintained on Monday, January 22 by SunTrust. The firm has “Buy” rating given on Wednesday, May 23 by Piper Jaffray. Deutsche Bank maintained Medidata Solutions, Inc. (NASDAQ:MDSO) on Wednesday, June 13 with “Buy” rating. The company was downgraded on Monday, May 21 by Morgan Stanley. On Friday, February 9 the stock rating was maintained by Morgan Stanley with “Overweight”. The firm has “Buy” rating by KeyBanc Capital Markets given on Wednesday, January 3. On Thursday, May 31 the stock rating was maintained by Deutsche Bank with “Buy”. The company was maintained on Thursday, February 8 by RBC Capital Markets. Dougherty maintained Medidata Solutions, Inc. (NASDAQ:MDSO) on Thursday, May 10 with “Buy” rating.

Medidata Solutions, Inc. provides cloud solutions for life sciences worldwide. The company has market cap of $4.80 billion. It offers Medidata Clinical Cloud that provides a software-as-a-service platform of technology and data analytics solutions to optimize activities across clinical development. It has a 109.46 P/E ratio. The companyÂ’s platform solutions includes Plan Study that addresses the areas to ensure optimal study design, grant development and negotiation, and investigator payments; and Support Sites, which provides robust risk management, reduced source document verification, real-time monitoring, on-time, accurate payments.

More important recent Medidata Solutions, Inc. (NASDAQ:MDSO) news were published by: Themiddlemarket.com which released: “M&A daily wrap: Medidata, Shyft Analytics, Audax, OEP, Naked Brand” on June 12, 2018, also Seekingalpha.com published article titled: “Medidata Solutions acquires SHYFT Analytics for $195M in cash”, Seekingalpha.com published: “Premarket analyst action – healthcare” on May 21, 2018. More interesting news about Medidata Solutions, Inc. (NASDAQ:MDSO) was released by: Streetinsider.com and their article: “Medidata Solutions (MDSO) PT Raised to $85 at Deutsche Bank” with publication date: May 31, 2018.

Medidata Solutions, Inc. (NASDAQ:MDSO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: